Business Segments Laboratorios Richmond S.A.C.I.F.

Stocks

End-of-day quote Buenos Aires S.E. Other stock markets 16/06/2026			5-day change	1st Jan Change
1,565.00 ^ARS	-1.88%		-1.57%	-20.76%

05-11	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI
05-08	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Breakdown by Business Segment (ARS)

Fiscal Period: December	2021	2022	2023	2024	2025
Private Market	5.91B	11.99B	32.64B	78.28B	101B
Gross Profit	3.28B	6.23B	18.49B	44.3B	65.66B
Net Income	290M	183M	-5.27B	13.42B	8.83B
Public Market - Others	3.02B	3.12B	4.97B	9.88B	19.62B
Gross Profit	1.06B	1.33B	1.77B	3.89B	8.91B
Net Income	141M	59.41M	-2.11B	907M	881M
Foreign Trade	458M	692M	1.42B	3.63B	6.22B
Gross Profit	210M	351M	295M	1.83B	3.62B
Net Income	8.49M	-197M	-583M	169M	1.01B
Public Market - Vaccines	7.22B	2.67B	-	-	-
Gross Profit	381M	817M	-	-	-
Net Income	-8.94M	-39.12M	-	-	-
Net Income	160M	156M	-2.89B	9.35B	-7.56B
Net Income	-	-	-	-	-80.43M
Public Market	-	-	-	-	-
Gross Profit	-	-	-	-	-
Net Income	-	-	-	-	-
Pharmaceutical Products
Pharmaceuticals	-	-	-	-	-
Interest Expense	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBT	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Net Income	-	-	-	-	-

Geographical breakdown of sales (ARS)

Fiscal Period: December	2021	2022	2023	2024	2025
Argentina	15.6B	18.64B	40.15B	92.98B	127B
Foreign	662M	624M	1.26B	3.28B	5.56B
Unallocated Refund for Exports	-	-	-	-	-
Unallocated Granted Discounts	-	-	-	-	-
Unallocated Bonuses and Returns	-	-	-	-	-
Unallocated Gross Income Tax	-	-	-	-	-
Unallocated	-401M	-790M	-2.38B	-4.46B	-5.81B